Ads
related to: biontech stock
Search results
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 5 hours agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
TD Cowen Raises BioNTech (NASDAQ:BNTX) Price Target to $98.00
ETF DAILY NEWS· 1 day agoThe brokerage currently has a hold rating on the stock. BMO Capital Markets cut their target price on BioNTech from $123.00 to $122.00 and set an outperform ...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 5 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 5 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
What's Going With BioNTech Stock On Monday?
Benzinga· 5 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BMO Capital cuts BioNTech stock target, keeps Outperform By Investing.com
Investing.com· 4 days agoOn Tuesday, BMO Capital Markets adjusted its price target for shares of BioNTech (NASDAQ:BNTX), a...
Kestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoKestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the 4th quarter, according to the company in its most...with ...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 21 hours agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 4 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...